It has been suggested that the embryonic microenvironment can control the survival and the transformed phenotype of tumour cells. Here, we addressed the hypothesis that the murine embryonic microenvironment can induce the differentiation of human tumour cells. To examine such interactions, we injected human leukaemic cells into preimplantation murine blastocysts at embryonic day 3.5 of gestation (E3.5). Microinjection of human KG-1 myeloid leukaemia cells and primary human acute myeloid leukaemia (AML) cells led to the generation of chimaeric embryos and adults. We observed that in E12.5 murine embryos, KG-1 cells were preferentially detected in yolk sac and peripheral blood, while primary AML cells mainly seeded the aorta gonad mesonephros region of chimaeric embryos. Analysis of the donor contribution in 15 different adult tissues showed that progeny of primary AML cells seeded to various haematopoietic and nonhaematopoietic tissues. Chimaeric embryos and adults showed no apparent tumour formation. Furthermore, analysis of chimaeric E12.5 embryos revealed that the progeny of human KG-1 cells activated erythroid-specific human globin and glycophorin A expression. In summary, our data indicate that human AML cells activate markers of erythroid differentiation after injection into early murine embryos. Oncogene (2003 Oncogene ( ) 22, 9185-9191. doi:10.1038 Keywords: acute myeloid leukaemia (AML); embryonic microenvironment Leukaemia is a cancer type caused by the deregulated proliferation of immature blood cells. The accumulation of a large number of nondifferentiating malignant myeloid precursor cells is a defining feature of acute myeloid leukaemia (AML) (Sachs, 1980) . Chromosomal translocations or inversions that destabilize normal cellular differentiation programmes are well-known molecular causes for most AMLs (Rabbitts, 1994; Look, 1997) . In AML, frequent molecular targets of chromosomal alterations are transcription factors that lead to a block at defined stages of differentiation (Alcalay et al., 2001) . Investigations into the organization of the AML cell system have revealed the presence of a hierarchical organization and transplantable leukaemic stem cells (Bonnet and Dick, 1997) .
Microinjection of murine embryonal carcinoma (EC) cells into murine blastocysts led to control of malignancy and participation of donor cells in normal murine embryogenesis, resulting in differentiation and development of normal chimaeric tissues (Brinster, 1974; Mintz and Illmensee, 1975a; Papaioannou et al., 1975) . Surprisingly, murine EC cells contributed to a wide range of somatic tissues and even functional sperms were produced (Mintz and Illmensee, 1975a; Illmensee and Mintz, 1976) . Further investigations revealed the necessity of signals from the inner cell mass and not by other components of the blastocyst such as zona pellucida or trophectoderm for control of tumorigenicity (Pierce et al., 1979) . In addition, murine myeloid leukaemic cells, neuroblastoma and melanoma cells were partially controlled by the microenvironment of developing midgestational mouse embryos (Gootwine et al., 1982; Pierce et al., 1982; Podesta et al., 1984; Gerschenson et al., 1986) . However, not all tumour cell types are controlled and only some EC cell lines generate normal cellular progeny upon blastocyst injection (Rossant and Papaioannou, 1985; Waters and Rossant, 1986) .
Here, we injected human leukaemic cells into murine blastocysts and followed their fate during murine embryogenesis and into adulthood. We provide evidence that upon injection of human KG-1 and primary AML cells, these leukaemic cells engraft early murine embryonic tissues. In addition, data presented here show that progeny of injected KG-1 cells express differentiation markers of the erythroid lineage in chimaeric tissues.
In previous reports we showed that, following the injection of murine adult bone marrow-derived lin This prompted us to investigate whether the injection of human AML cells into murine preimplantation blastocysts is compatible with normal murine embryogenesis and leads to haematopoietic engraftment in developing embryos. In our first series of experiments, we injected 5-40 human KG-1 AML cells (Koeffler and Golde, 1978) or primary AML cells from a leukaemic patient into murine blastocysts, and determined the chimaerism in mid-gestation E12.5 embryos and in adult animals. Tissue distribution of human cells in murine embryos was analysed using a semi-quantitative human chromosome 17-specific (17amod) PCR on genomic DNA.
Previous experiments with human HSCs had shown that 67% of injected blastocysts developed into embryos, whereby at E8.5 two out of 14 (2/14), at E11.5 9/20, and at E16.5 5/23 embryos were positive for human cells in at least one tissue . In three independent experiments human KG-1 cells were microinjected into a total of 174 murine blastocysts. In all, 31/174 (18%) of injected blastocysts developed into embryos. Of the developing E12.5 embryos, 14/31 (45%) were chimaeric ( Figure 1) . Similarly, when primary AML cells were injected into 52 blastocysts, 26 recipients (50%) developed and 14/26 (53%) of them carried progeny of injected primary AML cells ( Figure 2 ). The reduced frequency of embryos developing after KG-1 leukaemic cell injection compared to nonleukaemic HSCs injection suggests an adverse effect of the highly proliferative KG-1 cells on murine embryonic development. However, developing embryos and adults showed no signs of tumour formation by gross microscopic analysis and chimaeric adults were healthy when killed at 3 months of age.
Frequently, we detected human KG-1 cells in embryonic tissues, isolated at E12.5 (Figure 1 ). Of the 31 embryos that developed following KG-1 cell injection, human AML cell-derived engraftment was most frequent and had the highest contribution in the foetal blood (9/31) and yolk sac (5/31). The number of human cells present in chimaeric embryos was found to be in a range of 5-20 human donor cells per 100 000 murine peripheral blood cells. Based on the frequency of human cells in chimaeric foetal blood and the total number of E12.5 foetal blood cells of 6 x 10 6 (Barker, 1970) , the total number of KG-1 cells in peripheral blood was estimated to be in the range of 300-1200 cells. This number of human cells could only have been reached if the injected human cells underwent proliferation. In developing embryos, the level of chimaerism and tissue distribution following AML injection compare favourably with the contribution obtained with human cord blood CD34 þ /CD38 À HSCs . In contrast to KG-1 cells, injected human EOL-1 (eosinophilic leukaemia cell line) cells (Saito et al., 1985) showed no preference for foetal blood. Only 3/24 of the E12.5 embryos carried human donor cells in the foetal blood, other embryonic tissues contained donor cells with similar frequencies (data not shown). This indicates that not all human leukaemia cell lines preferentially engraft the peripheral blood following injection into murine blastocysts.
Next, we sought to isolate CD34 þ /CD38 À cells from the peripheral blood of a 78-year-old female patient with AML French-American-British (FAB)-type M 2 for microinjection into murine blastocysts. FACS analysis of the patient's peripheral blood cells, however, revealed only few (o1%) CD34 þ cells. As reported earlier, there is heterogeneity in the expression of cell surface determinants in AML samples (Terstappen et al., 1992; Bonnet and Dick, 1997) . Since no CD34 þ /CD38 À cells could be purified, only CD38 À cells were flow cytometrically isolated and injected. The progeny of the injected primary CD38
À AML cells were evident in 8 of the 14 developing E12.5 embryos obtained. Five out of 14 animals carried donor cells in the aorta-gonad-mesonephros (AGM) region ( Figure  2a, b) . The AGM region is the first intraembryonic tissue harbouring definitive HSCs in both mouse and man (Mu¨ller et al., 1994; Tavian et al., 1996) . Thus, human KG-1 and primary AML cells showed distinct engraftment properties in mid-gestational mouse embryos. Analysis of 15 different tissues of 12 adult animals aged 3 months developing after injection of CD38 À primary AML cells showed that six animals carried human donor cells. However, in contrast to chimaeric embryos, no preferential seeding of the injected AML tumour cells to adult haematopoietic sites was observed (Figure 2c, d) . The cellular nature of donor cells in adult tissues was not further analysed.
The first haematopoietic cells generated during ontogeny are erythroid cells. To test whether injected KG-1 cells express markers of erythroid differentiation, we performed RT-PCR specific for human e-and b-globin mRNA (Bungert et al., 1995) . RT-PCR analysis on proliferating KG-1 cells revealed no expression of the human globin genes, but upon phorbol ester treatment in vitro differentiation and erythroid-specific gene expression is induced (Figure 3) . Surprisingly, we detected transcripts of the human b-actin gene and erythroid-specific human e-and b-globin transcripts for yolk sac, foetal liver and foetal blood of E12.5 chimeric embryos. This finding illustrates that progeny of the injected human KG-1 tumour cells engraft foetal haematopoietic tissues and activate erythroid-specific genes suggesting commitment to erythroid differentiation.
To further analyse the donor contribution in chimaeric tissues, we utilized a monoclonal antibody that specifically recognizes human glycophorin A, a common marker of erythroid cells (Robinson et al., 1981; Outram et al., 1988) . To analyse whether KG-1 cells generate chimaeras with glycophorin A þ donor cells, a further series of blastocysts were injected. Peripheral blood cells of E12.5 embryos were isolated, cytospun and analysed by immunocytochemistry. Figure 4 shows the presence of human glycophorin A þ donor cells in the peripheral blood of two representative recipients (28 embryos analysed; nine embryos positive). In chimaeric peripheral blood samples, we detected among about 100 000 nucleated cells present on each slide on average 9.4 (min ¼ 2; max ¼ 22) glycophorin A þ donor cells. The samples displayed in Figure 4a , b contained in total 15 and 22 nucleated and glycophorin A þ cells, respectively. In control peripheral blood cells from a noninjected E12.5 embryo, none of the 100 000 cells were positive, while 198/200 human peripheral blood cells stained with the glycophorin A-specific antibody (Figure 4c, d) . The results from these experiments show that progeny of injected human KG-1 cells are present in the peripheral blood of developing embryos and that donor cells express a human erythroid-specific surface marker.
In this study, we have investigated whether human leukaemic AML cells can engraft murine embryos following injection into preimplantation blastocysts. In addition, we also analysed whether the murine embryonic microenvironment induced the leukaemic cells to differentiate. Previous studies suggested that some tumour cells could be induced to differentiate if injected into early murine embryos (Brinster, 1974; Mintz and Illmensee, 1975a; Papaioannou et al., 1975; Pierce et al., 1982; Gerschenson et al., 1986) . Here, we show that human leukaemic cells engraft into developing murine Total numbers of positive individuals among all 31 analysed embryos are given in the bottom line. Numbers represent chimaeric tissues per total number of tissues analysed. Murine preimplantation blastocysts were isolated from NMRI mice (Charles River) and 5-40 human KG-1 AML cells obtained from ATCC were microinjected into the blastocoelic cavity. Blastocysts were retransferred into pseudopregnant foster mothers and genomic DNA was prepared as described (Medvinsky et al., 1993; Mu¨ller et al., 1994) . Donor contribution was detected using semiquantitative human chromosome 17-specific PCR (17amod PCR; Warburton et al., 1991; Harder et al., 2002) on genomic DNA from different embryonic tissues. Graded numbers of human (hu) cells were diluted into 10 5 murine (mu) splenocytes for quantification of the PCR products. PCR specific for murine myogenin was used for normalization of genomic DNA. PCR products were separated on agarose gels and subjected to Southern blotting followed by hybridization with a 32 P-labelled DNA fragments and autoradiography. The injection of human cells into murine blastocysts was approved by the local ethics committee of the Medical Faculty, University of Wu¨rzburg. All animal experimentation was carried out using permitted procedures (Government of Unterfranken, Wu¨rzburg, Germany) embryos and that these human donor cells persist into adulthood. These results show that progeny of injected human KG-1 cells and of the primary human leukaemic cells were detected in a xenogenic environment in tissues with active haematopoiesis. The injected human cells presumably have properties for appropriate seeding to haematopoietic tissues despite the species difference and tumour phenotype. However, not all tested human cell types showed this property. We conclude that human KG-1 cells and the tested primary AML cells are able to seed murine embryonic haematopoietic tissues. Summary of tissue distribution of human cells in 3-month-old adult mice. Abbreviations: Br, brain; SC, spinal cord; NI, nervus ischiadicus; Li, liver; Lu, Lung; Gu, gut; He, heart; Mu, muscle; Go, gonads; Sp, spleen; Th, thymus; BM, bone marrow; Bl, peripheral blood; Sk, skin; Ki, kidney. The leukaemic peripheral blood specimen from a patient with AML was collected observing approved institutional procedures for obtaining informed consent according to the declaration of Helsinki (Ethics Committee, Medical Faculty, University of Frankfurt, Germany)
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Gene expression analysis by human-specific RT-PCR showed erythroid gene expression in KG-1 recipients. The finding that progeny of the injected human cells activate the human embryonic-specific e-globin as well as the adult-specific human b-globin gene may be due to the influence of the early murine embryonic environment on the injected human AML cells. This corresponds to the shift in globin gene expression from b-to e-globin seen after transplantation of adult murine bone marrow-derived HSCs into the embryonic microenvironment (Geiger et al., 1998) . In addition, immunocytochemical analysis of the peripheral blood from transplanted embryos revealed nucleated cells expressing the erythroid marker glycophorin A. These cells may either represent a population of nucleated human erythroid progenitors or indicate the presence of primitive-type human erythrocytes. The latter interpretation is supported by the detection of embryonic-type human e-globin transcripts in chimaeric yolk sac, foetal liver and foetal blood.
An alternative explanation for our results is cell fusion of donor and recipient cells. Cultured neural stem cells and bone marrow cells can adopt the phenotype of unrelated cell types in vitro by spontaneous cell fusion, and transplantation of bone marrow cells has regenerated livers with bone marrow-derived hepatocytes by cell fusion (Terada et al., 2002; Ying et al., 2002; Vassilopoulos et al., 2003; Wang et al., 2003) . Thus, the injected human leukaemic cells could have adopted the phenotype of erythroid cells by cell fusion with host cells. Although cell fusion seems to be a rare event both in vitro and in vivo and injections of even a low number of human cells gave consistent results, the frequency of cell fusion of injected cells in the murine embryo is unknown. Since our analysis does not address this question, it is unknown whether the human donor cells detected in chimaeric embryos and adults are products of cell fusion events.
Primary and KG-1 AML cell injection into NOD/SCID mice resulted in malignant engraftment (Junghahn et al., 2001) . The fact that in our study chimaeric adults did not show gross signs of tumour development may be due to differentiation or growth inhibition of injected AML cells. In concordance with differentiation is the observed human globin gene expression as well as the expression of the cell surface marker glycophorin A by progeny of injected KG-1 cells. Further analysis will reveal whether reisolated human cells from chimaeric animals have acquired further signs of differentiated cells or behave as tumour cells in vitro and in vivo.
What might be the underlying cause inducing some tumour cells to differentiate in embryonic environments? In EC cells, it is thought that epigenetic mechanisms are responsible for the reversibility of the malignant phenotypes (Stevens, 1967; Mintz et al., 1975b) . This occurs through unique cell-cell interactions and growth factor conditions within the early embryo that may influence the fate of the injected cells. Further evidence that the genome of malignant cells can generate apparently normal cell types was demonstrated by the cloning of murine embryos from medulloblastomas via nuclear transfer. Thus, epigenetic reprogramming by nuclear transfer can reverse oncogenesis (Li et al., 2003) . However, in contrast to EC cells or brain tumour cells, most AML cells develop as a result of genetic mutations (Look, 1997) . In this case, the silencing of the genetic abnormality may be sufficient for reversion of leukaemia. Indeed, KG-1 cells can be induced to differentiate partially in vitro (Koeffler et al., 1981; Drach et al., 1993) and the reversibility of bcr-abl-induced leukaemia by gene deletion or by kinase inhibitors has been demonstrated (Huettner et al., 2000; Sawyers, 2002) .
In conclusion, following their injection into early murine embryos, human leukaemic cells are able to contribute to haematopoietic tissues of developing Figure 3 Differentiate on-specific gene expression of human cells in chimaeric mice after injection of human KG-1 cells into murine blastocysts. Human globin gene expression was analysed in chimaeric E12.5 embryonic tissues (left). In parallel, KG-1 cells were induced to differentiate in vitro by Phorbol 12-myristate 13-acetate treatment (10 À7 M) for 48 and 72 h (right). Also shown are RTPCRs on RNA isolated from KG-1 cells, murine E12.5 foetal liver and human cord blood. For RT-PCR analysis, total RNA was extracted using RNAzol (BIOZOL), reverse transcribed with Omniscript reverse transcriptase (Qiagen) and normalized for differences in mRNA amounts using murine (mu) HPRT or human (hu) b-actin gene expression as an internal standard. Normalized cDNAs were subjected to human e and b-globin-specific PCR (Bungert et al., 1995; Lichtenberger et al., 1999) . Autoradiograms of PCR Southern blots are shown. Abbreviations: KG-1 1/500, KG-1 cDNA 1/500 diluted in H 2 O; CB, human cord blood murine embryos and adults. We also show that human leukaemic KG-1 cells express erythroid-specific genes in chimaeric midgestational animals suggesting that the murine embryonic microenvironment can induce the differentiation of tumour cells. It will therefore be important to identify the cellular mechanisms by which Figure 4 Human glycophorin A þ donor cells in chimaeric E12.5 peripheral blood after injection of KG-1 cells into murine blastocysts. Pictured are peripheral blood cells of two KG-1 transplant recipients (a, b), stainings of nontransplanted KG-1 cells (c), stainings of peripheral blood cells of a nontransplanted control embryo (d), and stainings of freshly isolated adult human peripheral blood cells (e). Analysis of representative samples are shown. Progeny of injected human KG-1 cells were detected in peripheral blood by staining with a human glycophorin A (CD235a)-specific rat monoclonal antibody (DPC Biermann). Glycophorin A-specific staining was visualized by an FITC-labelled goat anti-rat antibody (Jackson ImmunoResearch). Peripheral blood cells of E12.5 embryos were harvested, single cells were cytospun and subjected to a nuclear counter stain (4,6-diamidino-2-phenylindole (DAPI)) (blue) and glycophorin A-specific immunocytochemistry (green). Also shown are merged images of DAPI and glycophorin A-specific stainings. Magnification Â 1000 the embryonic microenvironment is capable of regulating tumour cell proliferation and differentiation.
